Rituximab-induced hypersensitivity pneumonitis in a kidney transplant patient
Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hypersensitivity pneumonitis associated with a single dose of RTX treatment in a kidney transplanted patient with acute antibody-mediated rejection.
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Sociedade Portuguesa de Nefrologia
2020
|
| Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692020000300010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|